Skip to main content
. 2018 Jun 20;21(2):173–181. doi: 10.4048/jbc.2018.21.2.173

Table 4. Results of proportional hazard Cox regression in 5 years OS and DFS among patients treated with neoadjuvant chemotherapy.

Survival Stage Survival No. (%) Death No. (%) Hazard ratio 95% CI p-value
OS
 Anatomic stage IA 291 (94.0) 19 (6.0) Reference - -
IB 40 (89.5) 6 (10.5) 1.8 0.7–4.5 0.2060
IIA 381 (93.1) 29 (6.9) 1.2 0.7–2.1 0.6290
IIB 205 (84.5) 41 (15.5) 2.7 1.6–4.7 0.0003
IIIA 151 (80.5) 37 (19.5) 3.5 2.0–6.1 < 0.0001
IIIB 32 (68.8) 15 (31.2) 6.2 3.2–12.3 < 0.0001
IIIC 111 (76.3) 37 (23.7) 4.5 2.6–7.8 < 0.0001
 Clinical prognostic stage IA 219 (94.7) 13 (5.3) Reference - -
IB 269 (94.9) 15 (5.1) 0.9 0.5–2.0 0.9275
IIA 312 (93.6) 22 (6.4) 1.2 0.6–2.4 0.5875
IIB 153 (82.7) 33 (17.3) 3.4 1.8–6.5 0.0002
IIIA 96 (83.6) 19 (16.4) 3.2 1.6–6.6 0.0011
IIIB 132 (75.1) 47 (24.9) 5.2 2.8–9.7 < 0.0001
IIIC 44 (56.3) 35 (43.7) 11.4 6.0–21.6 < 0.0001
DFS
 Anatomic stage IA 291 (94.3) 18 (5.7) Reference - -
IB 45 (89.5) 6 (10.5) 1.9 0.8–4.8 0.1703
IIA 381 (93.1) 29 (6.9) 1.2 0.7–2.2 0.5120
IIB 214 (84.5) 41 (15.5) 2.9 1.7–5.0 0.0002
IIIA 151 (81.0) 36 (19.0) 3.6 2.1–6.4 < 0.0001
IIIB 32 (68.8) 15 (31.2) 6.6 3.3–13.1 < 0.0001
IIIC 111 (76.3) 37 (23.7) 4.8 2.7–8.3 < 0.0001
 Clinical prognostic stage IA 219 (94.7) 13 (5.3) Reference - -
IB 269 (95.2) 14 (4.8) 0.9 0.4–1.9 0.7882
IIA 312 (93.6) 22 (6.4) 1.2 0.6–2.4 0.5874
IIB 153 (82.7) 33 (17.3) 3.4 1.8–6.5 0.0002
IIIA 96 (84.4) 18 (15.6) 3.1 1.5–6.3 0.0021
IIIB 132 (75.1) 47 (24.9) 5.2 2.8–9.7 < 0.0001
IIIC 44 (56.3) 35 (43.7) 11.5 6.1–21.7 < 0.0001

OS=overall survival; DFS=disease-free survival; CI=confidence interval.